Heart & lung : the journal of critical care
Majerus TC.
PMID: 1628999
Heart Lung. 1992 Jul-Aug;21(4):320-1.
No abstract available.
Cite
Majerus TC. Pharmacotherapy update. Heart Lung. 1992;21(4):320-1
Majerus, T. C. (1992). Pharmacotherapy update. Heart & lung : the journal of critical care, 21(4), 320-1.
Majerus, T C. "Pharmacotherapy update." Heart & lung : the journal of critical care vol. 21,4 (1992): 320-1.
Majerus TC. Pharmacotherapy update. Heart Lung. 1992 Jul-Aug;21(4):320-1. PMID: 1628999.
Copy
Download .nbib
Rivista dell'infermiere
Di Pasquale R, Romero M.
PMID: 7871342
Riv Inferm. 1994 Oct-Dec;13(4):246-66.
No abstract available.
Cite
Di Pasquale R, Romero M. Che cosa c'è di nuovo in terapia farmacologica? Anni 1992-1994. Parte terza. [What is new in drug therapy? 1992-1994. Part 3]. Riv Inferm. 1994;13(4):246-66
Di Pasquale, R., & Romero, M. (1994). Che cosa c'è di nuovo in terapia farmacologica? Anni 1992-1994. Parte terza. [What is new in drug therapy? 1992-1994. Part 3]. Rivista dell'infermiere, 13(4), 246-66.
Di Pasquale, R, and Romero, M. "Che cosa c'è di nuovo in terapia farmacologica? Anni 1992-1994. Parte terza." [What is new in drug therapy? 1992-1994. Part 3]. Rivista dell'infermiere vol. 13,4 (1994): 246-66.
Di Pasquale R, Romero M. Che cosa c'è di nuovo in terapia farmacologica? Anni 1992-1994. Parte terza. [What is new in drug therapy? 1992-1994. Part 3]. Riv Inferm. 1994 Oct-Dec;13(4):246-66. Italian. PMID: 7871342.
Copy
Download .nbib
Lancet (London, England)
Horrobin DF.
PMID: 12044395
Lancet. 2002 May 25;359(9320):1857-8. doi: 10.1016/S0140-6736(02)08707-X.
No abstract available.
Cite
Horrobin DF. Effective clinical innovation: an ethical imperative. Lancet. 2002;359(9320):1857-8doi: 10.1016/S0140-6736(02)08707-X.
Horrobin, D. F. (2002). Effective clinical innovation: an ethical imperative. Lancet (London, England), 359(9320), 1857-8. https://doi.org/10.1016/S0140-6736(02)08707-X
Horrobin, David F. "Effective clinical innovation: an ethical imperative." Lancet (London, England) vol. 359,9320 (2002): 1857-8. doi: https://doi.org/10.1016/S0140-6736(02)08707-X
Horrobin DF. Effective clinical innovation: an ethical imperative. Lancet. 2002 May 25;359(9320):1857-8. doi: 10.1016/S0140-6736(02)08707-X. PMID: 12044395.
Copy
Download .nbib
Harefuah
Reches A.
PMID: 16128012
Harefuah. 2005 Feb;144(2):95-6.
No abstract available.
Cite
Reches A. [Medicine--a victim of its own development]. Harefuah. 2005;144(2):95-6
Reches, A. (2005). [Medicine--a victim of its own development]. Harefuah, 144(2), 95-6.
Reches, A. "[Medicine--a victim of its own development]." Harefuah vol. 144,2 (2005): 95-6.
Reches A. [Medicine--a victim of its own development]. Harefuah. 2005 Feb;144(2):95-6. Hebrew. PMID: 16128012.
Copy
Download .nbib
Revue medicale suisse
Livio F, Buclin T, Biollaz J.
PMID: 16463801
Rev Med Suisse. 2006 Jan 11;2(48):155-9.
This article reviews some recent aspects of pharmacovigilance, of interest to the practitioner: biphosphonates and osteonecrosis of the jaw, antidepressants and suicide, antipsychotics and increased mortality risk and cerebrovascular events, withdrawal syndrome after in utero exposure to antidepressants SSRI,...
Cite
Livio F, Buclin T, Biollaz J. Pharmacovigitance--pharmaco-épidémiologie. [Trends in drug therapy]. Rev Med Suisse. 2006;2(48):155-9
Livio, F., Buclin, T., & Biollaz, J. (2006). Pharmacovigitance--pharmaco-épidémiologie. [Trends in drug therapy]. Revue medicale suisse, 2(48), 155-9.
Livio, F, et al. "Pharmacovigitance--pharmaco-épidémiologie." [Trends in drug therapy]. Revue medicale suisse vol. 2,48 (2006): 155-9.
Livio F, Buclin T, Biollaz J. Pharmacovigitance--pharmaco-épidémiologie. [Trends in drug therapy]. Rev Med Suisse. 2006 Jan 11;2(48):155-9. French. PMID: 16463801.
Copy
Download .nbib
JAMA
Schiff GD, Galanter WL.
PMID: 19244196
JAMA. 2009 Feb 25;301(8):865-7. doi: 10.1001/jama.2009.195.
No abstract available.
Cite
Schiff GD, Galanter WL. Promoting more conservative prescribing. JAMA. 2009;301(8):865-7doi: 10.1001/jama.2009.195.
Schiff, G. D., & Galanter, W. L. (2009). Promoting more conservative prescribing. JAMA, 301(8), 865-7. https://doi.org/10.1001/jama.2009.195
Schiff, Gordon D, and Galanter, William L. "Promoting more conservative prescribing." JAMA vol. 301,8 (2009): 865-7. doi: https://doi.org/10.1001/jama.2009.195
Schiff GD, Galanter WL. Promoting more conservative prescribing. JAMA. 2009 Feb 25;301(8):865-7. doi: 10.1001/jama.2009.195. PMID: 19244196.
Copy
Download .nbib
Nursing
Hussar DA.
PMID: 2027568
Nursing. 1991 May;21(5):41-5. doi: 10.1097/00152193-199105000-00016.
No abstract available.
Cite
Hussar DA. New drugs. Nursing. 1991;21(5):41-5doi: 10.1097/00152193-199105000-00016.
Hussar, D. A. (1991). New drugs. Nursing, 21(5), 41-5. https://doi.org/10.1097/00152193-199105000-00016
Hussar, D A. "New drugs." Nursing vol. 21,5 (1991): 41-5. doi: https://doi.org/10.1097/00152193-199105000-00016
Hussar DA. New drugs. Nursing. 1991 May;21(5):41-5. doi: 10.1097/00152193-199105000-00016. PMID: 2027568.
Copy
Download .nbib
American pharmacy
Hussar DA.
PMID: 2028913
Am Pharm. 1991 Mar;(3):54-84. doi: 10.1016/s0160-3450(15)31369-6.
No abstract available.
Cite
Hussar DA. New drugs of 1990. Am Pharm. 1991;(3):54-84doi: 10.1016/s0160-3450(15)31369-6.
Hussar, D. A. (1991). New drugs of 1990. American pharmacy, (3), 54-84. https://doi.org/10.1016/s0160-3450(15)31369-6
Hussar, D A. "New drugs of 1990." American pharmacy vol. ,3 (1991): 54-84. doi: https://doi.org/10.1016/s0160-3450(15)31369-6
Hussar DA. New drugs of 1990. Am Pharm. 1991 Mar;(3):54-84. doi: 10.1016/s0160-3450(15)31369-6. PMID: 2028913.
Copy
Download .nbib
Revista da Associacao Medica Brasileira (1992)
[No authors listed]
PMID: 15286839
Rev Assoc Med Bras (1992). 2004 Apr-Jun;50(2):109. doi: /S0104-42302004000200001. Epub 2004 Jul 21.
No abstract available.
Cite
A importância da medicina farmacêutica. [The importance of pharmaceutical medicine]. Rev Assoc Med Bras (1992). 2004;50(2):109doi: /S0104-42302004000200001.
(2004). A importância da medicina farmacêutica. [The importance of pharmaceutical medicine]. Revista da Associacao Medica Brasileira (1992), 50(2), 109. https://doi.org//S0104-42302004000200001
"A importância da medicina farmacêutica." [The importance of pharmaceutical medicine]. Revista da Associacao Medica Brasileira (1992) vol. 50,2 (2004): 109. doi: https://doi.org//S0104-42302004000200001
A importância da medicina farmacêutica. [The importance of pharmaceutical medicine]. Rev Assoc Med Bras (1992). 2004 Apr-Jun;50(2):109. doi: /S0104-42302004000200001. Epub 2004 Jul 21. Portuguese. PMID: 15286839.
Copy
Download .nbib
Perspectives in biology and medicine
Kassirer JP.
PMID: 17259672
Perspect Biol Med. 2007;50(1):7-17. doi: 10.1353/pbm.2007.0006.
Professional medical societies have become increasingly dependent on pharmaceutical, device, and biotechnology companies for ongoing support of their programs, but the internal influence of this financial largesse on medical societies' practices is well hidden. Many examples exist in which...
Cite
Kassirer JP. Professional societies and industry support: what is the quid pro quo?. Perspect Biol Med. 2007;50(1):7-17doi: 10.1353/pbm.2007.0006.
Kassirer, J. P. (2007). Professional societies and industry support: what is the quid pro quo?. Perspectives in biology and medicine, 50(1), 7-17. https://doi.org/10.1353/pbm.2007.0006
Kassirer, Jerome P. "Professional societies and industry support: what is the quid pro quo?." Perspectives in biology and medicine vol. 50,1 (2007): 7-17. doi: https://doi.org/10.1353/pbm.2007.0006
Kassirer JP. Professional societies and industry support: what is the quid pro quo?. Perspect Biol Med. 2007;50(1):7-17. doi: 10.1353/pbm.2007.0006. PMID: 17259672.
Copy
Download .nbib
The American journal of geriatric pharmacotherapy
Hanlon JT, Schmader KE.
PMID: 21821206
Am J Geriatr Pharmacother. 2011 Aug;9(4):211. doi: 10.1016/j.amjopharm.2011.07.001.
No abstract available.
Cite
Hanlon JT, Schmader KE. Dawn of a new era for the American journal of geriatric pharmacotherapy. Am J Geriatr Pharmacother. 2011;9(4):211doi: 10.1016/j.amjopharm.2011.07.001.
Hanlon, J. T., & Schmader, K. E. (2011). Dawn of a new era for the American journal of geriatric pharmacotherapy. The American journal of geriatric pharmacotherapy, 9(4), 211. https://doi.org/10.1016/j.amjopharm.2011.07.001
Hanlon, Joseph T, and Schmader, Kenneth E. "Dawn of a new era for the American journal of geriatric pharmacotherapy." The American journal of geriatric pharmacotherapy vol. 9,4 (2011): 211. doi: https://doi.org/10.1016/j.amjopharm.2011.07.001
Hanlon JT, Schmader KE. Dawn of a new era for the American journal of geriatric pharmacotherapy. Am J Geriatr Pharmacother. 2011 Aug;9(4):211. doi: 10.1016/j.amjopharm.2011.07.001. PMID: 21821206.
Copy
Download .nbib
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Autret-Leca E.
PMID: 16219451
Arch Pediatr. 2005 Dec;12(12):1748-51. doi: 10.1016/j.arcped.2005.09.014. Epub 2005 Oct 10.
No abstract available.
Cite
Autret-Leca E. Infos médicaments. [Drugs news]. Arch Pediatr. 2005;12(12):1748-51doi: 10.1016/j.arcped.2005.09.014.
Autret-Leca, E. (2005). Infos médicaments. [Drugs news]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 12(12), 1748-51. https://doi.org/10.1016/j.arcped.2005.09.014
Autret-Leca, E. "Infos médicaments." [Drugs news]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 12,12 (2005): 1748-51. doi: https://doi.org/10.1016/j.arcped.2005.09.014
Autret-Leca E. Infos médicaments. [Drugs news]. Arch Pediatr. 2005 Dec;12(12):1748-51. doi: 10.1016/j.arcped.2005.09.014. Epub 2005 Oct 10. French. PMID: 16219451.
Copy
Download .nbib
